These data suggest that despite a large infiltrate of T cells that are capable of effector function in PDA, there remains a bias towards immune suppression in the tumor microenvironment, due in part to a relative increase in the numbers of CD4+ Treg. This evidence concerns the gene CD4 and Patent ductus arteriosus.